Precision Medicine Research: Supporting Discovery and Innovation in the Study of Renal Disease

Authored by
Photo of the Late Manuel Velasquez, MD

The GW Medical Faculty Associates recently received a gift from Personalized Medicine Care Diagnostics (PMCDx), an advanced molecular diagnostic testing laboratory, in memory of Manny Velasquez, MD, Professor Emeritus of Medicine at GW SMHS and a long-time nephrologist at the GW MFA, who passed away in January 2021 just five days after his 82nd birthday.



The generous donation will support research into the use of precision medicine in treating renal disease at the GW MFA’s Kidney Precision Medicine Clinic. Through the gift, the clinic will launch pilot studies to test the utility of pharmacogenomics in transplant medicine to tailor immunosuppression.



“Dr. Velasquez dedicated his life to helping those in need and making a difference in countless lives,” said Sherry Dadgar, PhD ’13, clinical assistant professor of medicine in the Division of Kidney Disease and Hypertension, and founder and director of PMCDx. “His selflessness and kindness were an inspiration to all who knew him.”



She added, “this donation is a way to honor his memory and continue his legacy. We are grateful for the opportunity to contribute to a cause that Dr. Velasquez cared deeply about, and we hope that this donation helps to further his important work.”



The Kidney Precision Medicine Clinic was established to identify the gene variants associated with the kidney disease and deliver targeted treatment for the condition. 



“Identification of the genetic underpinning for the CKD may have a profound effect on the management of kidney disease,” explained Divya Shankaranarayanan, MBBS, assistant professor of medicine and the founding director of the Kidney Precision Medicine Clinic. “Genetic testing could not only avoid unnecessary treatments, but also permit use of specific therapy to which the condition is most likely to respond. Furthermore, unknowing the gene variant will alert the clinicians to look for not yet manifested multisystem diseases.”

Latest News

The GW Cancer Center announced the appointment of Katherine Chiappinelli, PhD, as Deputy Director for Basic Sciences. In this role, Chiappinelli will work with Edward Seto, PhD, associate center director for basic science at the GW Cancer Center, and the King Fahd Professor of Cancer Biology, to…
Paige McDonald, EdD ’12, MA, vice chair and associate professor in the Department of Clinical Research and Leadership (CRL), has been selected to serve as Interim Chair of the department. A leader in curriculum and educational innovation, McDonald has been a member of the GW faculty since 2008. An…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) welcomed the members of the MD Program Class of 2030 into the medical profession Aug. 29, during the school’s 28th Annual White Coat and Honor Code Ceremony at Lisner Auditorium.